Defining the pathway to insulin-like growth factor system targeting in cancer. - Wikidata - awgldk - TriplyDB

Defining the pathway to insulin-like growth factor system targeting in cancer.

Defining the pathway to insulin-like growth factor system targeting in cancer.

http://www.wikidata.org/entity/Q34107722

about

New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies Insulin-like growth factor system in cancer: novel targeted therapies Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers Cytohesins/ARNO: the function in colorectal cancer cells Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer.Insulin-like growth factor binding proteins: a structural perspective.Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein.Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.Apigenin Modulates Insulin-like Growth Factor Axis: Implications for Prevention and Therapy of Prostate Cancer.Novel tools for prostate cancer prognosis, diagnosis, and follow-up Survival of patients with lung cancer and diabetes mellitus.Insulin growth factor binding protein 2 mediates the progression of lymphangioleiomyomatosis.Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.Role of receptor tyrosine kinases and their ligands in glioblastoma.Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo.IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer.Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.Insulin-like growth factor system and sporadic malignant melanoma.Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells to EGFR-tyrosine kinase inhibitors.OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.Chemopreventive effects of tea in prostate cancer: green tea versus black tea.Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474 C57BL/KsJ-db/db-Apc mice exhibit an increased incidence of intestinal neoplasms.Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls.Acquired resistance to drugs targeting receptor tyrosine kinases Insulin-like growth factor receptor-1 and nuclear factor κB are crucial survival signals that regulate caspase-3-mediated lens epithelial cell differentiation initiation.TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma.Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway Insulin-like growth factor 1 regulates growth of endometrial carcinoma through PI3k signaling pathway in insulin-resistant type 2 diabetes Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.Ovary ecdysteroidogenic hormone functions independently of the insulin receptor in the yellow fever mosquito, Aedes aegypti Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.Current and future management strategies for relapsed or progressive hepatoblastoma.Klotho: a novel biomarker for cancer.

P2860

Q24619151-7247F983-0040-4937-B91C-1223C869DCE9 Q26823118-6F51D312-B866-472A-A46B-135E6470E8D6 Q28081603-BD8A434E-699A-4238-BC70-8B8096FFFA21 Q28484376-57B00820-C5A0-4C0C-852E-8315BF25145C Q28540770-B850DC77-0040-4265-B621-7539561A85E9 Q30384833-2694A230-8D19-4E14-AC9C-A6F4DEDD762F Q30417447-4668B040-361F-493B-9D7E-882CF99F5A86 Q30423008-95D7741B-5DEA-4E79-95A3-D2EA6576D876 Q33570283-018F367F-929D-4C6F-AA44-193022AD77D7 Q33611030-F77A1F49-3D5B-4DB0-9196-7A74490AC04D Q33625338-DA6A5812-7011-49BB-9914-83B28D2AAB92 Q33748272-B0DA9C74-7752-4EC9-B598-CD7D7B404D7F Q33829595-142B3D5B-F89A-4A13-90B4-3FDC9383B413 Q33845027-8F103B9E-7670-4313-9415-F5DB1E531ECC Q33883849-83B62E8D-E3B4-4246-B065-0C4136972504 Q34387886-0228019E-6813-4390-990B-C158A0269125 Q34477488-586693B6-B608-470D-A352-2D715CEC101F Q34556695-4725C263-36F7-4DF5-BC66-2E4C11FDDCF7 Q34673597-3136C7E7-B198-41C2-B0A3-3970E3740D48 Q34704781-7AF46363-48D6-458E-999D-924B1560F7A9 Q34756364-691FF6D7-BAA4-45B7-8191-B3828D7C28F9 Q35067488-6539887D-D554-4C6D-8C55-BE4746D46FA3 Q35131269-FFF278FC-3EC1-4A7F-B283-E52D321E3BFC Q35185534-677F80AA-9E51-403D-9DEC-0A4934466AFF Q35439316-5387B5D9-CE49-4A0D-BAE2-73AB37B54EBE Q35600230-92112647-B296-4852-9294-A1E1FECE542D Q35810171-183C349F-2EF8-41B6-A71C-FE07187CBB31 Q35823437-BC79BA80-2EAC-404F-98D9-7D2DC303CF7A Q36054645-66546F19-A563-4310-B510-9F47FB2F780D Q36238661-80AA0549-DF93-4752-B502-3BD5F542408F Q36412898-C3151BC8-6C2D-4CC3-831C-A5405CFEBA01 Q36413323-841EB5FD-3A1D-4374-A330-70670692192D Q36926139-14D84C6D-5BEB-42FC-9832-C8B9F930D833 Q37227957-0D6816BB-60ED-4A6C-A758-11AB85497D40 Q37354557-68240750-9D20-4010-8D09-7A43812B5C87 Q37450948-90E02FB0-2D1E-4A20-85D4-8A2B6F6D716C Q37889961-7DE5730D-C772-4C2E-A71B-AD5F42B354E8 Q37968256-20609791-22F6-453E-B665-0D34855EC046 Q38019027-13334CF6-6117-4092-AB99-22B2F4ADC3BA Q38236358-591CC47D-9F6B-4251-B521-0DCD4D4753F3

P2860

Defining the pathway to insulin-like growth factor system targeting in cancer.

http://www.wikidata.org/entity/Q34107722

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Defining the pathway to insulin-like growth factor system targeting in cancer.

@ast

Defining the pathway to insulin-like growth factor system targeting in cancer.

@en

Defining the pathway to insulin-like growth factor system targeting in cancer.

@nl

type

label

Defining the pathway to insulin-like growth factor system targeting in cancer.

@ast

Defining the pathway to insulin-like growth factor system targeting in cancer.

@en

Defining the pathway to insulin-like growth factor system targeting in cancer.

@nl

prefLabel

Defining the pathway to insulin-like growth factor system targeting in cancer.

@ast

Defining the pathway to insulin-like growth factor system targeting in cancer.

@en

Defining the pathway to insulin-like growth factor system targeting in cancer.

@nl

P1433

Q34107722-7677D519-05B4-4919-8F39-5A5C9E5BB077

P1476

Q34107722-2AD29E3A-BCE3-447C-858E-60B5FFFE6DBF

P2093

Q34107722-65C1BE54-4A6E-46E9-8FA4-E82BB902621D

Q34107722-E0A30AC6-43CC-4A03-8229-A61B2E2F8024

P2860

Q34107722-00279E0B-554D-4992-AAC8-A9A7363B1D32

Q34107722-0035BBD6-50CC-40C4-A485-6992007CC1AA

Q34107722-0215E2CA-AE29-4132-A5DD-61A19D8C7EC2

Q34107722-05212FE5-FF71-4331-9E87-DEB101FD5AE0

Q34107722-07369ED7-AEFC-4CB3-85B5-67A2983B6261

Q34107722-0C9098DC-9F6B-4B77-8574-621E7D0C237B

Q34107722-1108FCAD-F072-432C-A890-7C1DFE7759F5

Q34107722-153A1714-C689-4028-A315-1FEDBA466328

Q34107722-161510AD-E6F2-432B-9E8C-4E7514555F21

Q34107722-1B8F706C-05A5-4F4D-8095-06607AF4D958

P304

Q34107722-3FC75D17-A233-4E3B-9D01-69C5470A0A92

P31

Q34107722-7D5F413E-AECC-42E5-BA0C-F7AD4C453582

P356

Q34107722-E026A9E6-DB4B-4069-9122-E3A1112ED2FB

P407

Q34107722-E7CAF433-5984-4C86-9A31-2AD8DFF2AE75

P433

Q34107722-A4D00D3A-025E-4F95-B56A-F065063AA4D5

P478

Q34107722-DFE13707-DE32-48E2-80AF-099F255D346C

P577

Q34107722-349870DD-0CAA-409E-9CCC-57C7BE9445F6

P5875

Q34107722-15C729B7-1840-45C6-A1AA-5D2E2CEE6DF8

P698

Q34107722-2B81BB0A-CF3C-4BD1-B999-F069FD792D45

P921

Q34107722-78D65A1E-E0AE-45B7-A19E-A02D00D54E23

P932

Q34107722-6885348A-744F-4FC4-9C41-B25D4171D489

P356

J.BCP.2010.06.013

P1433

Biochemical Pharmacology

P1476

Defining the pathway to insulin-like growth factor system targeting in cancer.

@en

P2093

Hanudatta S Atreya

http://www.w3.org/2001/XMLSchema#string

Steven A Rosenzweig

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast

Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved

Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions

Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5

Rapid identification of small binding motifs with high-throughput phage display: discovery of peptidic antagonists of IGF-1 function

The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs

Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor

P304

1115-1124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BCP.2010.06.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45090910

http://www.w3.org/2001/XMLSchema#string

P698

20599789

http://www.w3.org/2001/XMLSchema#string

P921

P932

2934757

http://www.w3.org/2001/XMLSchema#string